Actavia Life Sciences, Inc. (RASP)

Actavia Life Sciences Ratios and Metrics

Market cap in millions USD. Fiscal year is October - September.

Total Valuation

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 24, 2025	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Market Capitalization	0	15	2	4	5	10
Market Cap Growth	-87.50%	603.00%	-46.89%	-20.00%	-50.00%	-68.75%
Enterprise Value	-	16	2	5	6	11
Last Close Price	0.00	0.02	0.01	0.06	0.07	0.15

Price Ratios

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 24, 2025	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
PB Ratio	-	-7.89	-1.30	-1.50	-1.93	4.07

Financial Efficiency

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 24, 2025	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Debt / Equity Ratio	-0.14	-0.11	-0.13	-0.25	-0.19	0.10
Net Debt / Equity Ratio	-0.14	-0.07	-0.11	-0.24	-0.19	0.09
Net Debt / EBITDA Ratio	-	-	-0.47	-2.71	-0.91	-0.24
Net Debt / FCF Ratio	-4.55	-15.97	-0.58	-2.29	-2.02	-2.32
Quick Ratio	0.00	0.04	0.02	0.00	0.01	0.02
Current Ratio	0.02	0.05	0.05	0.02	0.01	0.03
Return on Equity (ROE)	-	-	-	-	-	-33.19%
Return on Assets (ROA)	-427.68%	-2928.18%	-369.57%	-399.60%	-13.97%	-11.25%
Return on Capital Employed (ROCE)	15.80%	216.70%	24.00%	9.00%	20.80%	-36.10%

Yields

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Dec 24, 2025	Sep 30, 2023	Sep 30, 2022	Sep 30, 2021	Sep 30, 2020	Sep 30, 2019
Earnings Yield	-105.37%	-28.78%	-31.27%	-21.19%	-103.46%	-9.06%
FCF Yield	-17.22%	-0.06%	-14.24%	-7.10%	-4.86%	-0.90%
Buyback Yield / Dilution	-186.81%	-418.75%	-61.70%	-	-	-

Data Source: S&P Global Market Intelligence Last updated: May 20, 2024

Financial data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 16, 2026

Data Sources Report a data error